Plasma ω-3 fatty acid levels negatively and ω-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects

Asia Pacific Journal of Clinical Nutrition

Volumn 21, Issue 4, 2012, Pages 519-525

  Mehmetoglu, Idris ^a   Yerlikaya, F Hümeyra ^a   Kurban, Sevil ^a   Polat, Hakki ^a  

^a University of N Erbakan   (Turkey)

Author keywords

3 Fatty acids; 6 Fatty acids; Homocysteine; Obesity; Vitamin B 12

Indexed keywords

HOMOCYSTEINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ALGORITHM; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CYANOCOBALAMIN DEFICIENCY; ETHNOLOGY; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TURKEY (REPUBLIC);

ADULT; ALGORITHMS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TURKEY; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84871893543     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sheu WHH, Wu HS, Wang CW, Wan CJ, Lee WJ. Elevated plasma homocysteine concentrations six months after gastroplasty in morbidly obese subjects. Intern Med. 2001; 40:584-8.
2. Marchesini G, Manini R, Bianchi G, Sassi S, Natale S, Chierici S, Visani F, Baraldi L, Forlani G, Melchionda N. Homocysteine and psychological trait: a study in obesity. Nutrition. 2002;18:403-7.
3. Kalita J, Kumar G, Bansal V, Misra UK. Relationship of homocysteine with other risk factors and outcome of ischemic stroke. Clin Neurol Neurosur. 2009;111:364-7.
4. Vrentzos G, Papadakis JA, Malliaraki N, Zacharis EA, Katsogridakis K, Margioris AN. Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort. Angiology. 2004;55:517-24.
5. Gallistl S, Sudi K, Mangge H, Erwa W, Borkenstein M. Insulin is a independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care. 2000;23:1348-52.
6. Zhu W, Huang X, Li M, Neubauer H. Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis. Eur J Pediatr. 2006;165:326-31.
7. Vrentzos GE, Papadakis JA, Malliaraki N, Bampalis DE, Repa A, Lemonomichelaki V. Serum homocysteine concentration as a marker of nutritional status of healthy in Crete, Greece. J Hum Nutr Dietet. 2006;19:117-23.
8. Aarsetoey H, Pönitz V, Grundt H, Staines H, Harris WS, Nilsen DW. (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome. J Nutr. 2008;139:507-13.
9. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: A Critical Review. J Am Coll Nutr. 2001;20:5-19.
10. Morris MC, Sack F, Rosner B. Does fish oil lower blood pressure? Ameta-analysis of controlled trials. Circulation. 1993;88:523-33.
11. Svaneborg N, Moller JM, Scmidt EB, Varming K, Lervang HH, Dyerberg J. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids. 1994;29:145-7.
12. Hartung D, Stadeler M, Grieshaber R, Keller S, Jahreis G. Work and diet-related risk factors of cardiovascular diseases: comparison of two occupational groups. J Occup Med Toxicol. 2010;5:4.
13. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365-79.
14. Pooya Sh, Jalali MD, Jazayery AD, Saedisomeolia A, Eshraghian MR, Toorang F. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2010;20:326-31.
15. Beavers KM, Beavers DP, Bowden R, Wilson RL, Gentile M. Omega-3 fatty acid supplementation and total homocyteine levels in end-stage renal disease patients. Nephrology. 2008;13:284-8.
16. Li D, Yu XM, Xie HB, Zhang YH, Wang Q, Zhou XQ, Yu P, Wang LJ. Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandin Leukot Essent Fatty Acids. 2007;76:293-7.
17. Berstad P, Konstantinova SV, Refsum H, Nurk E, Vollset SE, Tell GS, Ueland PM, Drevon CA, Ursin G. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland homocysteine study. Am J Clin Nutr. 2007;85:1598-605.
18. Jacobsen DW. Determinants of hyperhomocysteinemia: a matter of nature and nurture. Am J Clin Nutr. 1996;64:641-2.
19. Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. Quantitative determination of plasma C8- C26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73: 38-45.
20. Piolot A, Blache D, Boulet L, Fortin LJ, Dubreuil D, Marcoux C, Davignon J, Lussier-Cacan S. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med. 2003;141:41-9.
21. Nenseter MS, Osterud B, Larsen T, Strøm E, Bergei C, Hewitt S, et al. Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals. Nutr Metab Cardiovasc Dis. 2000;10:323-30.
22. Grundt H, Nilsen DW, Hetland O, Mansoor MA. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clin Nutr. 2004;23:491-500.
23. Olszewski AJ, McCully KS. Fish oil decreases serum homocysteine in hyperlipemic men. Coron Artery Dis. 1993;4: 53-60.
24. Huang T, Wahlqvist ML, Li D. Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism. Nutr J. 2012;11:6.
25. Assies J, Lok A, Bockting CL, Weverling GJ, Lieverse R, Visser I, Abeling NG, Duran M, Schene AH. Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandin Leukot Essent Fatty Acids. 2004;70:349-56.
26. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, Chrysohoou C, Rousinou G, Toutouza M, Stefanadis C. Unsaturated acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clinica Chimica Acta. 2010;411:584-91.
27. Karatela RA, Sainani GS. Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. Indian Heart J. 2009;61:156-9.
28. Yun J, Kim JY, Kim OY, Jang Y, Chae JS, Kwak JH, Lim HH, Park HY, Lee SH, Lee JH. Associations of plasma homocysteine level with brachial-ankle pulse wave velocity, LDL atherogenicity, and inflammation profile in healthy men. Nutr Metab Cardiovasc Dis. 2011;21:136-43.
29. Terruzzi I, Senesi P, Fermo I, Lattuada G, Luzi L. Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity? J Endocrinol Invest. 2007; 30:747-53.
30. Brasileiro RS, Escrivao MA, Taddei JA, D'Almeida V, Ancona-Lopez F, Carvalhaes JT. Plasma total homocysteine in Brazilian overweight and non-overweight adolescents: a case-control study. Nutr Hosp. 2005;20:313-9.
31. Lin YH, Pao KY, Yang WS, Wu VC, Chen YJ, Lin YL, Tsai WS, Tsai IJ, Gau CS, Hwang JJ. Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease. Clin Chem Lab Med. 2008;46:125-30.
32. Hirsch S, Poniachick J, Avendano M, Csendes A, Burdiles P, Smok G, Diaz JC, de la Maza MP. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition. 2005;21:137-41.